Flutide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

81 API Suppliers, 31 USDMF, 30 CEP/COS, 6 JDMF, 7 EU WC, 2 KDMF, 27 NDC API, 47 Listed Suppliers

DEVELOPMENTS

168 Drugs in Development

168 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1275 FDF Dossiers, 77 FDA Orange Book, 982 Europe, 33 Canada, 76 Australia, 53 South Africa, 54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 4 Dr. Paul Lohmann GmbH & Co. KGaA, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 1 CD Formulation, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 12 Kerry, 3 Keval Exports, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

28 Fillers, Diluents & Binders, 22 Thickeners and Stabilizers, 21 Solubilizers, 21 Topical, 19 Parenteral, 17 Direct Compression, 15 Granulation, 13 Disintegrants & Superdisintegrants, 10 Emulsifying Agents, 10 Co-Processed Excipients, 8 Controlled & Modified Release, 7 Surfactant & Foaming Agents, 7 Film Formers & Plasticizers, 5 Rheology Modifiers, 5 Coating Systems & Additives, 5 API Stability Enhancers, 4 Taste Masking, 4 Chewable & Orodispersible Aids, 1 Lubricants & Glidants

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 149 News #PharmaBuzz

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 96 Regulatory FDF Prices, 14 Annual Reports

MARKET PLACE

19 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

122 US Patents, 1 US Exclusivities, 97 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 USP, 19 Others

Xls

Filters

FILTER :

filter Product Reset all filters

14 All

01 3Dymista

02 1Flixotide

03 1Flixotide /Flovent

04 9Flixotide/Flovent

01 Brand Name : Flixotide/Flovent

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

02 Brand Name : Flixotide/Flovent

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

03 Brand Name : Flixotide/Flovent

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

04 Brand Name : Dymista

Azelastine Hydrochloride, Fluticasone Propionate

Stanford Drug Discovery Symposium

Not Confirmed

05 Brand Name : Flixotide/Flovent

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

06 Brand Name : Dymista

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

07 Brand Name : Dymista

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

08 Brand Name : Flixotide/Flovent

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

09 Brand Name : Flixotide /Flovent

Azelastine Hydrochloride, Fluticasone Propionate

Bioprocess International Europe

Not Confirmed

10 Brand Name : Flixotide

Azelastine Hydrochloride, Fluticasone Propionate

Sampe

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Flutide

Flutide

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

81 API Suppliers

31 USDMF

30 CEP/COS

6 JDMF

7 EU WC

2 KDMF

27 NDC API

47 Listed Suppliers

DEVELOPMENTS

168 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1275 FDF Dossiers

77 FDA Orange Book

982 Europe

33 Canada

76 Australia

53 South Africa

54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY

SPRAY, METERED;NASAL - 0.05MG/SPRAY

POWDER;INHALATION - 0.05MG/INH

POWDER;INHALATION - 0.1MG/INH

POWDER;INHALATION - 0.25MG/INH

POWDER;INHALATION - 0.03MG/INH

POWDER;INHALATION - 0.055MG/INH

POWDER;INHALATION - 0.113MG/INH

POWDER;INHALATION - 0.232MG/INH

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH

LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.044MG/INH

AEROSOL, METERED;INHALATION - 0.11MG/INH

AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

2 SPI Pharma

3 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

6 Kirsch Pharma

4 Dr. Paul Lohmann GmbH & Co. KGaA

10 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

11 BASF

1 CD Formulation

5 DFE Pharma

2 Finar

7 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

1 Ingredion Pharma Solutions

12 Kerry

3 Keval Exports

1 Kima Chemical

10 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

10 Roquette

OINTMENT;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons